Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion
Identifieur interne : 003236 ( Main/Merge ); précédent : 003235; suivant : 003237Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion
Auteurs : Birgit Meiler [Allemagne] ; Jürgen Andrich [Allemagne] ; Thomas Müller [Allemagne]Source :
- Movement Disorders [ 0885-3185 ] ; 2008-01.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Levodopa.
- chemical , therapeutic use : Levodopa.
- drug therapy : Parkinson Disease.
- Administration, Oral, Aged, Drug Therapy, Combination, Duodenum, Female, Humans, Infusions, Parenteral, Jejunostomy, Male, Time Factors.
Abstract
Six patients with Parkinson's disease (PD) with severe motor complications were directly switched from their oral antiparkinsonian combination drug regime to nasoduodenal levodopa infusion without previously recommended transient treatment with levodopa alone. Duodenal levodopa infusion reduced motor complications to a considerable extent. We have shown that a prior change to an oral levodopa monotherapy and a slow titration of duodenal levodopa infusion may be skipped and a direct switch to duodenal levodopa is a safe option. © 2007 Movement Disorder Society
Url:
DOI: 10.1002/mds.21800
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 003A52
- to stream Istex, to step Curation: 003A52
- to stream Istex, to step Checkpoint: 001214
- to stream PubMed, to step Corpus: 002459
- to stream PubMed, to step Curation: 002459
- to stream PubMed, to step Checkpoint: 002109
- to stream Ncbi, to step Merge: 001F00
- to stream Ncbi, to step Curation: 001F00
- to stream Ncbi, to step Checkpoint: 001F00
Links to Exploration step
ISTEX:5DCFC4E8E36DC490766CE1CC6C104E652EB04FF3Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion</title><author><name sortKey="Meiler, Birgit" sort="Meiler, Birgit" uniqKey="Meiler B" first="Birgit" last="Meiler">Birgit Meiler</name></author><author><name sortKey="Andrich, Jurgen" sort="Andrich, Jurgen" uniqKey="Andrich J" first="Jürgen" last="Andrich">Jürgen Andrich</name></author><author><name sortKey="Muller, Thomas" sort="Muller, Thomas" uniqKey="Muller T" first="Thomas" last="Müller">Thomas Müller</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5DCFC4E8E36DC490766CE1CC6C104E652EB04FF3</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/mds.21800</idno><idno type="url">https://api.istex.fr/document/5DCFC4E8E36DC490766CE1CC6C104E652EB04FF3/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003A52</idno><idno type="wicri:Area/Istex/Curation">003A52</idno><idno type="wicri:Area/Istex/Checkpoint">001214</idno><idno type="wicri:doubleKey">0885-3185:2008:Meiler B:rapid:switch:from</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:17987653</idno><idno type="wicri:Area/PubMed/Corpus">002459</idno><idno type="wicri:Area/PubMed/Curation">002459</idno><idno type="wicri:Area/PubMed/Checkpoint">002109</idno><idno type="wicri:Area/Ncbi/Merge">001F00</idno><idno type="wicri:Area/Ncbi/Curation">001F00</idno><idno type="wicri:Area/Ncbi/Checkpoint">001F00</idno><idno type="wicri:Area/Main/Merge">003236</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion</title><author><name sortKey="Meiler, Birgit" sort="Meiler, Birgit" uniqKey="Meiler B" first="Birgit" last="Meiler">Birgit Meiler</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, St. Josef Hospital, Ruhr University Bochum, 44791 Bochum</wicri:regionArea><wicri:noRegion>44791 Bochum</wicri:noRegion><wicri:noRegion>44791 Bochum</wicri:noRegion></affiliation></author><author><name sortKey="Andrich, Jurgen" sort="Andrich, Jurgen" uniqKey="Andrich J" first="Jürgen" last="Andrich">Jürgen Andrich</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, St. Josef Hospital, Ruhr University Bochum, 44791 Bochum</wicri:regionArea><wicri:noRegion>44791 Bochum</wicri:noRegion><wicri:noRegion>44791 Bochum</wicri:noRegion></affiliation></author><author><name sortKey="Muller, Thomas" sort="Muller, Thomas" uniqKey="Muller T" first="Thomas" last="Müller">Thomas Müller</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, St. Josef Hospital, Ruhr University Bochum, 44791 Bochum</wicri:regionArea><wicri:noRegion>44791 Bochum</wicri:noRegion><wicri:noRegion>44791 Bochum</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-01">2008-01</date><biblScope unit="vol">23</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="145">145</biblScope><biblScope unit="page" to="146">146</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">5DCFC4E8E36DC490766CE1CC6C104E652EB04FF3</idno><idno type="DOI">10.1002/mds.21800</idno><idno type="ArticleID">MDS21800</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Oral</term><term>Aged</term><term>Drug Therapy, Combination</term><term>Duodenum</term><term>Female</term><term>Humans</term><term>Infusions, Parenteral</term><term>Jejunostomy</term><term>Levodopa (administration & dosage)</term><term>Levodopa (therapeutic use)</term><term>Male</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson's disease</term><term>Time Factors</term><term>levodopa infusion</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Oral</term><term>Aged</term><term>Drug Therapy, Combination</term><term>Duodenum</term><term>Female</term><term>Humans</term><term>Infusions, Parenteral</term><term>Jejunostomy</term><term>Male</term><term>Time Factors</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Six patients with Parkinson's disease (PD) with severe motor complications were directly switched from their oral antiparkinsonian combination drug regime to nasoduodenal levodopa infusion without previously recommended transient treatment with levodopa alone. Duodenal levodopa infusion reduced motor complications to a considerable extent. We have shown that a prior change to an oral levodopa monotherapy and a slow titration of duodenal levodopa infusion may be skipped and a direct switch to duodenal levodopa is a safe option. © 2007 Movement Disorder Society</div></front></TEI><double doi="10.1002/mds.21800"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion</title><author><name sortKey="Meiler, Birgit" sort="Meiler, Birgit" uniqKey="Meiler B" first="Birgit" last="Meiler">Birgit Meiler</name></author><author><name sortKey="Andrich, Jurgen" sort="Andrich, Jurgen" uniqKey="Andrich J" first="Jürgen" last="Andrich">Jürgen Andrich</name></author><author><name sortKey="Muller, Thomas" sort="Muller, Thomas" uniqKey="Muller T" first="Thomas" last="Müller">Thomas Müller</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:5DCFC4E8E36DC490766CE1CC6C104E652EB04FF3</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/mds.21800</idno><idno type="url">https://api.istex.fr/document/5DCFC4E8E36DC490766CE1CC6C104E652EB04FF3/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">003A52</idno><idno type="wicri:Area/Istex/Curation">003A52</idno><idno type="wicri:Area/Istex/Checkpoint">001214</idno><idno type="wicri:doubleKey">0885-3185:2008:Meiler B:rapid:switch:from</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion</title><author><name sortKey="Meiler, Birgit" sort="Meiler, Birgit" uniqKey="Meiler B" first="Birgit" last="Meiler">Birgit Meiler</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, St. Josef Hospital, Ruhr University Bochum, 44791 Bochum</wicri:regionArea><wicri:noRegion>44791 Bochum</wicri:noRegion><wicri:noRegion>44791 Bochum</wicri:noRegion></affiliation></author><author><name sortKey="Andrich, Jurgen" sort="Andrich, Jurgen" uniqKey="Andrich J" first="Jürgen" last="Andrich">Jürgen Andrich</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, St. Josef Hospital, Ruhr University Bochum, 44791 Bochum</wicri:regionArea><wicri:noRegion>44791 Bochum</wicri:noRegion><wicri:noRegion>44791 Bochum</wicri:noRegion></affiliation></author><author><name sortKey="Muller, Thomas" sort="Muller, Thomas" uniqKey="Muller T" first="Thomas" last="Müller">Thomas Müller</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, St. Josef Hospital, Ruhr University Bochum, 44791 Bochum</wicri:regionArea><wicri:noRegion>44791 Bochum</wicri:noRegion><wicri:noRegion>44791 Bochum</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-01">2008-01</date><biblScope unit="vol">23</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="145">145</biblScope><biblScope unit="page" to="146">146</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">5DCFC4E8E36DC490766CE1CC6C104E652EB04FF3</idno><idno type="DOI">10.1002/mds.21800</idno><idno type="ArticleID">MDS21800</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>levodopa infusion</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Six patients with Parkinson's disease (PD) with severe motor complications were directly switched from their oral antiparkinsonian combination drug regime to nasoduodenal levodopa infusion without previously recommended transient treatment with levodopa alone. Duodenal levodopa infusion reduced motor complications to a considerable extent. We have shown that a prior change to an oral levodopa monotherapy and a slow titration of duodenal levodopa infusion may be skipped and a direct switch to duodenal levodopa is a safe option. © 2007 Movement Disorder Society</div></front></TEI></ISTEX><PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion.</title><author><name sortKey="Meiler, Birgit" sort="Meiler, Birgit" uniqKey="Meiler B" first="Birgit" last="Meiler">Birgit Meiler</name><affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, St. Josef Hospital, Ruhr University Bochum, 44791 Bochum, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, St. Josef Hospital, Ruhr University Bochum, 44791 Bochum</wicri:regionArea><wicri:noRegion>44791 Bochum</wicri:noRegion><wicri:noRegion>44791 Bochum</wicri:noRegion><wicri:noRegion>44791 Bochum</wicri:noRegion></affiliation></author><author><name sortKey="Andrich, Jurgen" sort="Andrich, Jurgen" uniqKey="Andrich J" first="Jürgen" last="Andrich">Jürgen Andrich</name></author><author><name sortKey="Muller, Thomas" sort="Muller, Thomas" uniqKey="Muller T" first="Thomas" last="Müller">Thomas Müller</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2008">2008</date><idno type="doi">10.1002/mds.21800</idno><idno type="RBID">pubmed:17987653</idno><idno type="pmid">17987653</idno><idno type="wicri:Area/PubMed/Corpus">002459</idno><idno type="wicri:Area/PubMed/Curation">002459</idno><idno type="wicri:Area/PubMed/Checkpoint">002109</idno><idno type="wicri:Area/Ncbi/Merge">001F00</idno><idno type="wicri:Area/Ncbi/Curation">001F00</idno><idno type="wicri:Area/Ncbi/Checkpoint">001F00</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion.</title><author><name sortKey="Meiler, Birgit" sort="Meiler, Birgit" uniqKey="Meiler B" first="Birgit" last="Meiler">Birgit Meiler</name><affiliation wicri:level="1"><nlm:affiliation>Department of Neurology, St. Josef Hospital, Ruhr University Bochum, 44791 Bochum, Germany.</nlm:affiliation><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, St. Josef Hospital, Ruhr University Bochum, 44791 Bochum</wicri:regionArea><wicri:noRegion>44791 Bochum</wicri:noRegion><wicri:noRegion>44791 Bochum</wicri:noRegion><wicri:noRegion>44791 Bochum</wicri:noRegion></affiliation></author><author><name sortKey="Andrich, Jurgen" sort="Andrich, Jurgen" uniqKey="Andrich J" first="Jürgen" last="Andrich">Jürgen Andrich</name></author><author><name sortKey="Muller, Thomas" sort="Muller, Thomas" uniqKey="Muller T" first="Thomas" last="Müller">Thomas Müller</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="eISSN">1531-8257</idno><imprint><date when="2008" type="published">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Oral</term><term>Aged</term><term>Drug Therapy, Combination</term><term>Duodenum</term><term>Female</term><term>Humans</term><term>Infusions, Parenteral</term><term>Jejunostomy</term><term>Levodopa (administration & dosage)</term><term>Levodopa (therapeutic use)</term><term>Male</term><term>Parkinson Disease (drug therapy)</term><term>Time Factors</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Oral</term><term>Aged</term><term>Drug Therapy, Combination</term><term>Duodenum</term><term>Female</term><term>Humans</term><term>Infusions, Parenteral</term><term>Jejunostomy</term><term>Male</term><term>Time Factors</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Six patients with Parkinson's disease (PD) with severe motor complications were directly switched from their oral antiparkinsonian combination drug regime to nasoduodenal levodopa infusion without previously recommended transient treatment with levodopa alone. Duodenal levodopa infusion reduced motor complications to a considerable extent. We have shown that a prior change to an oral levodopa monotherapy and a slow titration of duodenal levodopa infusion may be skipped and a direct switch to duodenal levodopa is a safe option.</div></front></TEI></PubMed></double></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003236 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003236 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Merge
|type= RBID
|clé= ISTEX:5DCFC4E8E36DC490766CE1CC6C104E652EB04FF3
|texte= Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion
}}
| This area was generated with Dilib version V0.6.23. |  |